Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced the launch of two new master mixes...
Environmental Impact Acquisition Corporation ("ENVI" or the "Company") announced that it had achieved a quorum for the special meeting of its shareholders to be...
Akeso, Inc. announces that the Ligufalimab (CD47 monoclonal antibody, research and development code: AK117, the novel immuno-oncology drug independently developed by the Company) and...
COVID-19 has irrevocably changed the landscape of the healthcare industry. The rapid digitalization of this industry has demonstrated that we as consumers have quickly...
